Compare INN & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INN | VSTM |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 470.7M |
| IPO Year | 2011 | 2012 |
| Metric | INN | VSTM |
|---|---|---|
| Price | $4.49 | $6.65 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $4.50 | ★ $14.50 |
| AVG Volume (30 Days) | 743.0K | ★ 1.8M |
| Earning Date | 02-25-2026 | 03-19-2026 |
| Dividend Yield | ★ 7.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $727,443,000.00 | $13,379,000.00 |
| Revenue This Year | $0.77 | $208.54 |
| Revenue Next Year | $1.97 | $251.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 33.79 |
| 52 Week Low | $3.57 | $4.01 |
| 52 Week High | $6.78 | $11.25 |
| Indicator | INN | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 41.54 | 46.33 |
| Support Level | $4.34 | $6.26 |
| Resistance Level | $4.51 | $7.05 |
| Average True Range (ATR) | 0.15 | 0.41 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 25.20 | 59.13 |
Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.